Skip to content

Immunodeficiency 64 C5231402

Published: July 22, 2026Updated: August 20, 2026

A rare genetic primary immunodeficiency affecting immune system function, making affected individuals highly susceptible to infections.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe disseminated viral infection (e.g., CMV disease)

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Recurrent bacterial infections

(immunologic)

Eczema-like skin lesions

(dermatologic)

Autoimmune thyroid disease

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunoglobulin Replacement Therapy

Regular IVIG or subcutaneous immunoglobulin therapy forms the cornerstone of treatment, providing broad-spectrum antibody coverage and reducing infectious complications.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Aggressive Infection Management

Prompt initiation of broad-spectrum antimicrobials at first signs of infection, with subsequent narrowing based on culture results, to prevent sepsis and complications.

medication

Additional treatment options

Immunologic Parameter Tracking

Serial measurements of immunoglobulin levels, lymphocyte subsets, and vaccine responses guide therapy adjustments and indicate disease progression or improvement.

monitoring

Stem Cell Transplant Assessment

Comprehensive evaluation for hematopoietic stem cell transplantation candidacy in patients with severe phenotype or inadequate response to conventional therapy.

procedure

Nutritional Optimization

High-protein diet with micronutrient supplementation supports immune function and muscle mass maintenance, particularly important during recovery from recurrent infections.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Immunodeficiency 64 C5231402?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Immunodeficiency 64 C5231402. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy